NewAmsterdam Pharma Co N.V. (NAMS) — Revenue
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $22.50M | -50.6% |
| 2024 | $45.56M | +223.4% |
| 2023 | $14.09M | -86.3% |
| 2022 | $102.69M | — |
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $22.50M | -50.6% |
| 2024 | $45.56M | +223.4% |
| 2023 | $14.09M | -86.3% |
| 2022 | $102.69M | — |